Eperisone transdermal - Eisai

Drug Profile

Eperisone transdermal - Eisai

Alternative Names: E 2000; Myonal Transdermal Patch

Latest Information Update: 07 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Eisai Co Ltd
  • Class Analgesics; Antiepileptic drugs; Muscle relaxants; Neuroprotectants; Piperidines; Propiophenones; Small molecules; Vasodilators
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Muscle hypertonia

Most Recent Events

  • 10 Feb 2004 Phase-III clinical trials in Hypertonia in Japan (Transdermal)
  • 09 May 2000 Preregistration for Hypertonia in Japan (Transdermal)
  • 28 Jan 2000 Preregistration for Hypertonia in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top